Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
DNLI
Stock Latest News
The Fly
Denali Therapeutics price target lowered to $28 from $30 at BofA
16h ago
DNLI
Premium
The Fly
Denali Therapeutics assumed with an Overweight at Morgan Stanley
4d ago
DNLI
Premium
Ratings
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
5d ago
DNLI
Premium
Company Announcements
Denali Therapeutics Discontinues DNL343 ALS Trial
5d ago
8K
DNLI
Premium
The Fly
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
5d ago
DNLI
Premium
The Fly
Denali Therapeutics price target lowered to $35 from $38 at B. Riley
6d ago
DNLI
Premium
The Fly
Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer
8d ago
DNLI
Premium
Ratings
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
8d ago
DNLI
Premium
The Fly
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
11d ago
DNLI
Premium
Ratings
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
11d ago
DNLI
Premium
Ratings
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
11d ago
DNLI
Premium
The Fly
Denali Therapeutics price target lowered to $80 from $87 at H.C. Wainwright
11d ago
DNLI
Premium
Company Announcements
Denali Therapeutics Reports 2024 Financial Results and Progress
11d ago
DNLI
Premium
Company Announcements
Denali Therapeutics Signs New Equity Distribution Deal
11d ago
8K
DNLI
Premium
The Fly
Denali Therapeutics reports Q4 EPS (67c), consensus (85c)
11d ago
DNLI
Premium
The Fly
Denali Therapeutics files automatic mixed securities shelf
11d ago
DNLI
Premium
The Fly
Denali Therapeutics initiated with a Buy at Deutsche Bank
28d ago
DNLI
Premium
The Fly
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
1M ago
DNLI
Premium
Company Announcements
Denali Therapeutics Outlines 2025 Milestones and Strategies
2M ago
8K
DNLI
Premium
The Fly
Denali Therapeutics announces U.S. FDA BTD granted for tividenofusp
2M ago
DNLI
Premium
The Fly
Denali recent pullback a buying opportunity, says Jefferies
2M ago
DNLI
Premium
The Fly
BofA trims Denali Therapeutics price target to $30, says weakness an opportunity
2M ago
DNLI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
